PT  - JOURNAL ARTICLE
AU  - Cristina Scarpazza
AU  - Gianluca Musumeci
AU  - Andrea S. Camperio Ciani
TI  - The importance of the human factor during the evolution of SARS-CoV-2 pandemic: the successful case of the Italian strategy
AID  - 10.1101/2020.10.22.20215277
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.22.20215277
4099  - http://medrxiv.org/content/early/2020/10/27/2020.10.22.20215277.short
4100  - http://medrxiv.org/content/early/2020/10/27/2020.10.22.20215277.full
AB  - In Italy, 311,364 cases and 35,851 deaths of people who tested positive for SARS-CoV-2 were registered as of September 29th, 2020. To avoid the spreading of the virus, mathematical models predicting the course of infection’s spread1 become the basis to plan stringent countermeasures. We applied a published algorithm to real data up to September 27th, modeling two scenarios where predicted and real data were compared: a conservative scenario with a lockdown still ongoing and a scenario reflecting what actually happened in Italy, where the lockdown has been removed. Results revealed that the number of individuals in life-threatening condition is much lower than predicted, as well as the number of symptomatic individuals. Contrarily, the number of asymptomatic individuals is much higher than predicted. This suggest that human beings are not passive victims, but active fighters able to change the course of the infection creating adaptive strategies against the infection’s spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo founds have been receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was needed as the manuscript analyzed published dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Italian official data are available at the following link: https://github.com/pcm-dpc/COVID-19 The Matlab source code for this paper, including the modified algorithms from the original publication, can be found at the following link: https://drive.google.com/drive/folders/1EB1oLlxsWI7Xjs-5p6Zd-xrIz6fbkV1a?usp=sharing